Group Leader, Antibody‑Oligonucleotide Conjugates (Extrahepatic Delivery)

Requisition ID: 1667 • Posting Start Date: 10/04/2026

The Nucleic Acid Therapeutics Initiative (NATi), hosted by A*STAR, is Singapore's national platform dedicated to advancing RNA‑based medicines and revolutionizing drug and vaccine development. NATi's mission is to establish Singapore as a globally recognised hub for nucleic acid therapeutics research, clinical translation and commercialisation. It focuses on key RNA modalities such as antisense oligonucleotides (ASOs), small interfering RNA (siRNA) and messenger RNA (mRNA), and builds a biotech‑like translational engine from discovery to clinical development.

We seek a highly innovative and results‑driven Group Leader to build and lead an interdisciplinary team developing antibody‑oligonucleotide conjugates (AOCs) for extrahepatic delivery. The role integrates antibody discovery and e...